- Home
- GEOS vs PROK Comparison
GEOS vs PROK Comparison
Compare GEOS & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEOS
- PROK
- Stock Information
- Founded
- GEOS 1980
- PROK 2015
- Country
- GEOS United States
- PROK United States
- Employees
- GEOS N/A
- PROK N/A
- Industry
- GEOS Industrial Machinery/Components
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GEOS Industrials
- PROK Health Care
- Exchange
- GEOS Nasdaq
- PROK Nasdaq
- Market Cap
- GEOS 72.9M
- PROK 85.5M
- IPO Year
- GEOS 1997
- PROK N/A
- Fundamental
- Price
- GEOS $12.40
- PROK $4.74
- Analyst Decision
- GEOS
- PROK Buy
- Analyst Count
- GEOS 0
- PROK 4
- Target Price
- GEOS N/A
- PROK $5.33
- AVG Volume (30 Days)
- GEOS 503.2K
- PROK 33.2M
- Earning Date
- GEOS 08-07-2025
- PROK 08-08-2025
- Dividend Yield
- GEOS N/A
- PROK N/A
- EPS Growth
- GEOS N/A
- PROK N/A
- EPS
- GEOS N/A
- PROK N/A
- Revenue
- GEOS $116,542,000.00
- PROK $306,000.00
- Revenue This Year
- GEOS N/A
- PROK $54.34
- Revenue Next Year
- GEOS N/A
- PROK N/A
- P/E Ratio
- GEOS N/A
- PROK N/A
- Revenue Growth
- GEOS N/A
- PROK N/A
- 52 Week Low
- GEOS $5.51
- PROK $0.46
- 52 Week High
- GEOS $18.99
- PROK $7.13
- Technical
- Relative Strength Index (RSI)
- GEOS 55.56
- PROK 92.14
- Support Level
- GEOS $12.60
- PROK $0.54
- Resistance Level
- GEOS $14.38
- PROK $7.13
- Average True Range (ATR)
- GEOS 1.80
- PROK 0.62
- MACD
- GEOS -0.32
- PROK 0.47
- Stochastic Oscillator
- GEOS 38.67
- PROK 68.59
About GEOS Geospace Technologies Corporation (Texas)
Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.